Clinical Trials · NCT07319832
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Takeda
- Enrollment
- 12
- Start date
- Mar 2026
- Locations
- 4 sites, China
- Primary endpoint
- Percentage of Participants Who Achieve at Least a 20% Reduction from Baseline in Weekly Parenteral Support (PS) Volume at Week 24